HIV Persistence in Lymph Node and Peripheral Blood

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

October 17, 2018

Study Completion Date

October 17, 2018

Conditions
HIV-1-infection
Interventions
PROCEDURE

Leukapheresis

Blood will be taken by a needle inserted into a vein in one arm and processed through a machine, which spins the blood so that the white blood cells will be separated out of the machine for purposes of this research. The rest of the blood will be returned through a needle in the other arm.

PROCEDURE

Lymph node biopsy

Ultrasound will be used to localize the position of one lymph node in the groin. Under a light general anesthetic, one lymph node will be removed.

Trial Locations (1)

3181

Alfred Hospital, Melbourne

All Listed Sponsors
collaborator

amfAR, The Foundation for AIDS Research

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

Monash University

OTHER

collaborator

Université de Montréal

OTHER

collaborator

The Avenue Hospital

UNKNOWN

collaborator

Oregon Health and Science University

OTHER

collaborator

Johns Hopkins University

OTHER

lead

University of Melbourne

OTHER

NCT03426189 - HIV Persistence in Lymph Node and Peripheral Blood | Biotech Hunter | Biotech Hunter